Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RI0194
Host Cell : HEK293 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RI0194 |
| Description | This cell line is engineered to overexpress human TRPC6. |
| Background | The human TRPC6 gene encodes the pore-forming subunit of TRPC6, a non-selective, cation-permeable channel. TRPC6 channels are therapeutic targets in asthma, COPD, cancer, and pulmonary hypertension. |
| Target Gene | TRPC6 |
| Gene Species | Homo sapiens (Human) |
| Abbr | HEK293-HuTRPC6 |
| Alias | TRPC6, TRP6, TRP-6, FSGS2, FLJ11098, FLJ14863 |
| Host Cell | HEK293 |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Channelopathies research |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Media Type | Cells were cultured in DMEM supplemented with 10% fetal bovine serum. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Freeze Medium | Complete medium supplemented with 10% (v/v) DMSO |
| Morphology | Epithelial |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | TRPC6 transient receptor potential cation channel, subfamily C, member 6 [ Homo sapiens ] |
| Gene Symbol | TRPC6 |
| Synonyms | TRP6; FSGS2 |
| GeneID | 7225 |
| Uni ProtID | Q9Y210 |
| mRNA Refseq | NM_004621.5 |
| Protein Refseq | NP_004612.2 |
| Chromosome Location | 11q22.1 |
| Function | inositol 1,4,5 trisphosphate binding; protein binding; store-operated calcium channel activity; |
| Pathway | Axon guidance, organism-specific biosystem; Developmental Biology, organism-specific biosystem; EPO signaling pathway, organism-specific biosystem; Effects of PIP2 hydrolysis, organism-specific biosystem; Elevation of cytosolic Ca2+ levels, organism-specific biosystem; Endothelins, organism-specific biosystem; G alpha (q) signalling events, organism-specific biosystem; |
| MIM | 603652 |
The actin cytoskeleton of podocytes plays a central role in the function of the renal filtration barrier. Calcium influx into podocytes via TRPC6 (transient receptor potential canonical 6) channels triggers actin cytoskeleton rearrangement, thereby affecting the filtration barrier. Researchers hypothesized the existence of a feedback mechanism wherein the cytoskeleton regulates TRPC6 channel activity. Experiments using scanning ion conductance microscopy demonstrated altered migration characteristics in podocyte cultures treated with cytochalasin D, a drug that disrupts the actin cytoskeleton. Cell-attached patch-clamp recordings revealed that cytochalasin D enhanced TRPC6 channel activity in TRPC6-overexpressing CHO (Chinese hamster ovary) cells and in podocytes within freshly isolated glomeruli. Furthermore, previous studies have shown that mutations in the ACTN4 gene-which encodes α-actinin-4-cause focal segmental glomerulosclerosis and lead to the stiffening of the actin network within podocytes. Consequently, researchers investigated whether α-actinin-4 regulates TRPC6 channel activity. The results showed that co-expression of the mutant α-actinin-4 K255E with TRPC6 in CHO cells reduced TRPC6 channel activity. Collectively, these data confirm a direct interaction between the structure of the actin cytoskeleton and TRPC6 activity.
To investigate how the disruption of actin cytoskeleton dynamics regulates TRPC6, researchers examined the effect of cytochalasin D on TRPC6 channel activity. Several members of the TRPC family-including TRPC3, TRPC5, and TRPC6-have been implicated in the pathogenesis of proteinuric kidney disease. Therefore, to explore the role of the actin cytoskeleton in TRPC6 channel function, the researchers generated TRPC6-overexpressing CHO cells. In the cell-attached recording configuration, the addition of 10 µM cytochalasin D to the bath solution induced single-channel activation (Figure 1a), with a current-voltage relationship characteristic of TRPC6 (Figure 1b). The addition of cytochalasin D did not alter the conductance of the recorded channels. The positive reversal potential observed in the current-voltage curve reflected the cell's plasma membrane potential. Upon excision of the membrane patch to the inside-out configuration, the reversal potential shifted to 0 mV, and the conductance increased to 23 ± 1 pS (n = 6). Control cells transfected only with GFP exhibited no TRPC6 activity either before or after the addition of cytochalasin D. Following the addition of cytochalasin D, the basal activity (NPo) of the overexpressed TRPC6 channels increased (Figure 1c). In experimental groups that did not initially exhibit basal activity, 10 µM cytochalasin D was still able to activate TRPC6 channels, albeit at lower activity levels-likely reflecting a smaller number of active channels. Overall, the NPo increased from 0.45 ± 0.23 to 1.69 ± 0.66 (Figure 1c).
Figure 1. Effect of cytochalasin D on TRPC6 channels overexpressed in CHO cells. (Shalygin A, et al., 2021)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Switching to this TRPC6 HEK293 stable line vastly improved our assay window. The baseline noise is minimal, and the receptor expression levels are exceptionally high. The comprehensive QC data provided by Creative Biogene gave us great confidence right out of the box.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.